뉴스
- D&D Pharmatech tumbles 18% after Pfizer halts ORALINK candidate [K-bio pulse] D&D Pharmatech shares dropped sharply after it was confirmed that development had been halted on an obesity drug candidate built with the company's technology.
- Kolon TissueGene Escapes Fourth Limit-Down; Peptron Jumps After Hours[K-Bio Pulse] South Korea’s biotech sector showed sharp divergence on July 24. Kolon TissueGene narrowly avoided a fourth consecutive limit-down close, while Peptron su
- Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the dai